Dysferlin Regulates Cell Adhesion in Human Monocytes


Por: de Morree, A, Flix, B, Bagaric, I, Wang, J, van den Boogaard, M, Moursel, LG, Frants, RR, Illa, I, Gallardo, E, Toes, R, van der Maarel, SM

Publicada: 17 may 2013
Resumen:
Dysferlin is mutated in a group of muscular dystrophies commonly referred to as dysferlinopathies. It is highly expressed in skeletal muscle, where it is important for sarcolemmal maintenance. Recent studies show that dysferlin is also expressed in monocytes. Moreover, muscle of dysferlinopathy patients is characterized by massive immune cell infiltrates, and dysferlin-negative monocytes were shown to be more aggressive and phagocytose more particles. This suggests that dysferlin deregulation in monocytes might contribute to disease progression, but the molecular mechanism is unclear. Here we show that dysferlin expression is increased with differentiation in human monocytes and the THP1 monocyte cell model. Freshly isolated monocytes of dysferlinopathy patients show deregulated expression of fibronectin and fibronectin-binding integrins, which is recapitulated by transient knockdown of dysferlin in THP1 cells. Dysferlin forms a protein complex with these integrins at the cell membrane, and its depletion impairs cell adhesion. Moreover, patient macrophages show altered adhesion and motility. These findings suggest that dysferlin is involved in regulating cellular interactions and provide new insight into dysferlin function in inflammatory cells.

Filiaciones:
de Morree, A:
 Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands

Flix, B:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Lab Neurol Expt, Serv Neurol, Bellaterra 08193, Spain

 Univ Autonoma Barcelona, Inst Recerca, HSCSP, Bellaterra 08193, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra 08193, Spain

Bagaric, I:
 Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands

Wang, J:
 Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands

van den Boogaard, M:
 Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands

Moursel, LG:
 Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands

Frants, RR:
 Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands

Illa, I:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Lab Neurol Expt, Serv Neurol, Bellaterra 08193, Spain

 Univ Autonoma Barcelona, Inst Recerca, HSCSP, Bellaterra 08193, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra 08193, Spain

Gallardo, E:
 Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Lab Neurol Expt, Serv Neurol, Bellaterra 08193, Spain

 Univ Autonoma Barcelona, Inst Recerca, HSCSP, Bellaterra 08193, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra 08193, Spain

Toes, R:
 Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands

van der Maarel, SM:
 Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands
ISSN: 00219258





JOURNAL OF BIOLOGICAL CHEMISTRY
Editorial
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 288 Número: 20
Páginas: 14147-14157
WOS Id: 000319253500019
ID de PubMed: 23558685
imagen Green Published, Hybrid Gold

MÉTRICAS